May 28, 2020
Nagasaki University President Shigeru Kono Nagasaki University plans to start an investigator-initiated trial for Japan Tobacco’s now-discontinued HIV medicine nelfinavir for the treatment of COVID-19, expecting that it might be effective in the early phase of the disease, President Shigeru...read more